{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T17:04:19Z","timestamp":1769879059069,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T00:00:00Z","timestamp":1462838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Taiwan Centers for Disease Control","award":["MOHW103-CDC-C-114-000405"],"award-info":[{"award-number":["MOHW103-CDC-C-114-000405"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jmii.2016.04.011","type":"journal-article","created":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T18:14:43Z","timestamp":1463163283000},"page":"38-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Incidence and risk factors of herpes zoster in human immunodeficiency virus-positive patients initiating combination antiretroviral therapy in Taiwan"],"prefix":"10.1016","volume":"51","author":[{"given":"Yi-Chieh","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Ching","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8096-3063","authenticated-orcid":false,"given":"Mao-Song","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang-Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Zhen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsi-Yen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Chun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-Chwen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2016.04.011_bib1","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/infdis\/166.5.1153","article-title":"Herpes zoster and human immunodeficiency virus infection","volume":"166","author":"Buchbinder","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2016.04.011_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.qai.0000178408.62675.b0","article-title":"The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era","volume":"40","author":"Gebo","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jmii.2016.04.011_bib3","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1086\/315146","article-title":"Zoster incidence in human immunodeficiency virus-infected hemophiliacs and homosexual men, 1984\u20131997","volume":"180","author":"Engels","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2016.04.011_bib4","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/00002030-199510000-00006","article-title":"Herpes zoster, immunological deterioration and disease progression in HIV-1 infection","volume":"9","author":"Veenstra","year":"1995","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2016.04.011_bib5","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0190-9622(86)70127-8","article-title":"Herpes zoster: a possible early clinical sign for development of acquired immunodeficiency syndrome in high-risk individuals","volume":"14","author":"Friedman-Kien","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jmii.2016.04.011_bib6","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/clinids\/21.2.370","article-title":"Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus","volume":"21","author":"Glesby","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2016.04.011_bib7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1258\/095646205774357271","article-title":"Herpes zoster in HIV-1-infected patients in the era of highly active antiretroviral therapy: a prospective observational study","volume":"16","author":"Hung","year":"2005","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jmii.2016.04.011_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/cid\/cit165","article-title":"Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era","volume":"57","author":"Moanna","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2016.04.011_bib9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/1471-2334-13-372","article-title":"Incidence and risk factors of herpes zoster among HIV-positive patients in the German Competence Network for HIV\/AIDS (KompNet): a cohort study analysis","volume":"13","author":"Jansen","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jmii.2016.04.011_bib10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/QAI.0b013e318266cd3c","article-title":"Herpes zoster among persons living with HIV in the current antiretroviral therapy era","volume":"61","author":"Blank","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jmii.2016.04.011_bib11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2334-13-170","article-title":"Similar herpes zoster incidence across Europe: results from a systemic literature review","volume":"13","author":"Pinchinat","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jmii.2016.04.011_bib12","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/archinte.1995.00430150071008","article-title":"The incidence of herpes zoster","volume":"155","author":"Donahue","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jmii.2016.04.011_bib13","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jmii.2016.04.011_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00126334-200501010-00020","article-title":"The incidence of herpes zoster is less likely than other opportunistic infections to be reduced by highly active antiretroviral therapy","volume":"38","author":"Vanhems","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jmii.2016.04.011_bib15","article-title":"Live attenuated herpes zoster vaccine for HIV-infected adults","author":"Shafran","year":"2015","journal-title":"HIV Med"},{"key":"10.1016\/j.jmii.2016.04.011_bib16","unstructured":"Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. AIDSinfo website. Available from: https:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adult_oi.pdf. [accessed 10.01.16]."},{"key":"10.1016\/j.jmii.2016.04.011_bib17","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Eng J Med"},{"key":"10.1016\/j.jmii.2016.04.011_bib18","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/infdis\/jiu606","article-title":"Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1\/2a randomized, placebo-controlled study","volume":"211","author":"Berkowitz","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2016.04.011_bib19","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/cid\/ciu1161","article-title":"Incidence of herpes zoster in HIV-infected adults in the combined anteritroviral therapy era: results from the FHDH-ANRS CO4 cohort","volume":"60","author":"Grabar","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2016.04.011_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijid.2013.10.016","article-title":"Incidence and predictors of herpes zoster among antiretroviral therapy-na\u00efve patients initiating HIV treatment in Johannesburg, South Africa","volume":"23","author":"Shearer","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jmii.2016.04.011_bib21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9343(01)00703-3","article-title":"Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection","volume":"110","author":"Domingo","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.jmii.2016.04.011_bib22","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1086\/515019","article-title":"High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors","volume":"27","author":"Martinez","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2016.04.011_bib23","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jmii.2016.04.011_bib24","first-page":"1528","article-title":"Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jmii.2016.04.011_bib25","first-page":"153","article-title":"Recombinant subunit vaccines: potentials and constraints","volume":"121","author":"Clark","year":"2005","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.jmii.2016.04.011_bib26","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/0895-4356(94)90132-5","article-title":"The accuracy of self-report of herpes zoster","volume":"47","author":"Schmader","year":"1994","journal-title":"J Clin Epidemiol"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S168411821630041X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S168411821630041X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:21:41Z","timestamp":1761657701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S168411821630041X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S168411821630041X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2016.04.011","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and risk factors of herpes zoster in human immunodeficiency virus-positive patients initiating combination antiretroviral therapy in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2016.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}